Eugia Pharma receives USFDA Approval for Dasatinib Tablets Eugia Pharma receives USFDA Approval for Dasatinib Tablets The company has a market cap of over Rs 70,000 crore and the stock is up by 23 per cent from its 52-week low of Rs 994.35 per share. DSIJ Intelligence-1 / Wednesday, April 23, 2025 0 146 Article rating: 5.0 The company has a market cap of over Rs 70,000 crore and the stock is up by 23 per cent from its 52-week low of Rs 994.35 per share. Read more
Pharmaceuticals Company Gets USFDA Approval For Phytonadione Injectable Emulsion Pharmaceuticals Company Gets USFDA Approval For Phytonadione Injectable Emulsion The stock gave multibagger returns of 190 per cent in 2 years and a whopping 500 per cent in 5 years. DSIJ Intelligence-1 / Wednesday, April 23, 2025 0 216 Article rating: 4.4 The stock gave multibagger returns of 190 per cent in 2 years and a whopping 500 per cent in 5 years. Read more
Pharma company receives final ANDA approval for Rivaroxaban Tablets USP, 2.5mg & tentative approval for other strengths of Rivaroxaban Tablets USP Pharma company receives final ANDA approval for Rivaroxaban Tablets USP, 2.5mg & tentative approval for other strengths of Rivaroxaban Tablets USP Aurobindo Pharma Limited announced obtaining the last approval from the US Food & Drug Administration (USFDA) for Rivaroxaban Tablets USP, 2.5 mg. DSIJ Intelligence-1 / Monday, April 14, 2025 0 165 Article rating: 5.0 The biosimilars division alongside niche product development represents Aurobindo Pharma's main focus areas where its 1500 scientists dedicate their efforts. Read more
Medical Equipment & Supplies Expands Global Reach in Medical Devices; Secures USFDA Registration Medical Equipment & Supplies Expands Global Reach in Medical Devices; Secures USFDA Registration Company's products are available both online, through its proprietary store and major e-commerce platforms, and offline, with a presence in over 22,000 retail touchpoints across 460+ towns in India. DSIJ Intelligence-1 / Monday, April 14, 2025 0 187 Article rating: 5.0 The company's wholly-owned subsidiary, Nureca Technologies Pvt Ltd, specializes in manufacturing medical devices with an annual capacity of 8 lakh units. Read more
Pharma Company Has Received Final Approval From United States Food and Drug Administration For Abbreviated New Drug Application Pharma Company Has Received Final Approval From United States Food and Drug Administration For Abbreviated New Drug Application The company has a market cap of over Rs 1 lakh crore and the stock is up by 13 per cent from its 52-week low of Rs 1,310.05 per share. DSIJ Intelligence-1 / Sunday, April 13, 2025 0 428 Article rating: 4.7 The company has a market cap of over Rs 1 lakh crore and the stock is up by 13 per cent from its 52-week low of Rs 1,310.05 per share. Read more
Multibagger Pharma Stock Rises Nearly 3 Per Cent After US FDA Observations on Telangana Facility Multibagger Pharma Stock Rises Nearly 3 Per Cent After US FDA Observations on Telangana Facility The inspection, conducted between December 9 and December 17, 2024, resulted in two procedural observations from the US FDA. DSIJ Intelligence / Wednesday, December 18, 2024 0 221 Article rating: 4.3 The facility in question, Unit-V, is an active pharmaceutical ingredient (API) manufacturing site operated by Apitoria Pharma Private Ltd, a wholly owned subsidiary of Aurobindo Pharma, located in Pashamylaram Village, Telangana. Read more
Indian Pharma Company Scores Major USFDA Approval for Game-Changing Capsule, Plans 5+ New Product Launches! Indian Pharma Company Scores Major USFDA Approval for Game-Changing Capsule, Plans 5+ New Product Launches! With the USFDA's green light, the Indian pharmaceutical company is poised to expand its product portfolio and strengthen its global presence DSIJ Intelligence / Monday, November 11, 2024 0 219 Article rating: 5.0 With the USFDA's green light, the Indian pharmaceutical company is poised to expand its product portfolio and strengthen its global presence Read more
This pharma company's shares surged to a new 52-week high after receiving final approval from the USFDA. This pharma company's shares surged to a new 52-week high after receiving final approval from the USFDA. The share has delivered over 95 per cent returns in the past year, transforming into a multi-bagger with over 260 per cent returns in the last two years. DSIJ Intelligence / Friday, August 9, 2024 0 351 Article rating: 3.7 The share has delivered over 95 per cent returns in the past year, transforming into a multi-bagger with over 260 per cent returns in the last two years. Read more
This pharma company stock went 8 per cent high, do you own it? This pharma company stock went 8 per cent high, do you own it? With its shares up 8 per cent, the Indian multinational pharmaceutical company posted a net profit of Rs 130 crore in the second quarter, while its turnover increased to Rs 4,145 crore. DSIJ Intelligence-1 / Thursday, November 10, 2022 0 1426 Article rating: 5.0 This pharma company stock went 8 per cent high, do you own it? With its shares up 8 per cent, the Indian multinational pharmaceutical company posted a net profit of Rs 130 crore in the second quarter, while its turnover increased to Rs 4,145 crore. Read more
Heavy buying seen in these small-caps that hit fresh 52 week high on August 18! Heavy buying seen in these small-caps that hit fresh 52 week high on August 18! On BSE, 265 stocks have hit their upper circuits whereas 131 stocks touched their lower circuits.  DSIJ Intelligence / Thursday, August 18, 2022 0 5837 Article rating: 4.2 At 2.30 pm on Thursday, the markets were seen recovering from the day’s low as Asia- Pacific markets tumbled following the overnight cooling off of the most recent Wall Street rise. Read more
Lupin hit the ball out of the park! Is the tide turning in favour of the stock after this big announcement? Lupin hit the ball out of the park! Is the tide turning in favour of the stock after this big announcement? DSIJ Intelligence-3 / Tuesday, December 14, 2021 0 747 Article rating: 3.7 Another interesting point is that it’s not very usual these days to see pharma stock jumping 8-9 per cent but on Tuesday, Lupin broke this jinx as it soared nearly 9 per cent. Certainly, this might have brought a million-dollar smile to the faces of Lupin investors. Read more